17th Hong Kong International Wine & Spirits Fair wraps up on a high note with over 8,200 buyers 
The 33rd Hong Kong International Optical Fair attracts some 12,000 buyers 
TSplus Remote Support 4.3: Faster, Smarter, and More User-Friendly Than Ever 
KOCCA’s WelCon Marketplace Expands Global K-Content Collaboration with 2025 Virtual Exchange Event Precision Home Pros Offers State-of-the Art Home Automation Security Measures
The Texas-based all-purpose smart home and security firm wishes to highlight that it offers the…
Gratomic to Trade Graphite on TM2 Metals Exchange
First Canadian company to be listed on the world’s first Technology Metals Market TORONTO, ON…
Is coronavirus still a danger, even if I’m vaccinated? A new rapid test needs just 10 minutes to show whether you have had the intended immune response
Levels of uncertainty are running high: the particularly contagious delta variant continues to spread. Although…
Anthony Woodward appointed Logicalis Australia CEO
London | 30th June 2021 – Logicalis, an international IT solutions and managed services provider,…
Staff, Patients & Visitors Get Automatic, Secure Access to Wi-Fi 6 and WBA OpenRoaming™ Across Multiple Hospital Campuses
24 Adventist Health hospital campuses will gain access to fast, seamless and secure Wi-Fi without…
Zylpha Launches ‘Pay As You Bundle’ Software Format For Peppermint CX & SharePoint Online Users
New ‘Pay As You Go’ connectors have made legal document bundling faster, more efficient and…
ISARA Corp. Introduces Advance Crypto Agility Suite to Address Critical Cryptographic Blind Spots
Software gives organizations control and insight into their information security infrastructures to minimize vulnerabilities and…
HUTCHMED Announces the Closing of the Global Offering and the Primary Listing in Hong Kong
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., June 30, 2021 (GLOBE NEWSWIRE) —…
Change in Number of Shares and Votes in Immunicum AB (publ)
Press Release 30 June 2021 Change in Number of Shares and Votes in Immunicum AB…
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial…
Emergex Receives Regulatory Approval for a Phase I Clinical Trial in Dengue of a T-Cell Priming Vaccine
PRESS RELEASE Emergex Receives Regulatory Approval for a Phase I Clinical Trial in Dengue of…
OSE Immunotherapeutics Announces Manufacturing Agreement with Cenexi for Clinical Batches of CoVepiT, OSE’s Multi-Target Second-Generation COVID-19 Vaccine
NANTES, France and FONTENAY-SOUS-BOIS, France, June 30, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173;…
ObsEva Presents Clinical Data on Open-Label Pilot Study of Yselty® (linzagolix) for the Treatment of Severe Adenomyosis at ESHRE Virtual 37th Annual Meeting
-Two additional abstracts presented on data from ongoing clinical programs: Yselty for the treatment of…
Addex Establishes At-The-Market ADS Equity Sale Program
Geneva, Switzerland, June 30, 2021 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering…
Bone Therapeutics publishes results of ALLOB Phase I/IIa study for the treatment of delayed-union fractures in Stem Cell Research & Therapy
Results showed percutaneous implantation of allogeneic bone-forming cells was well tolerated in patients and led…
PANBELA THERAPEUTICS INCREASES PREVIOUSLY ANNOUNCED BOUGHT DEAL OFFERING OF COMMON STOCK TO $10.0 MILLION
MINNEAPOLIS, June 30, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the “Company” or…
Aerovate Therapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON, June 29, 2021 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage…
MedMira Reports Third Quarter Results FY2021
HALIFAX, Nova Scotia, June 29, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported…
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., June 29, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
Fennec Announces Results of Annual Meeting
RESEARCH TRIANGLE PARK, N.C., June 29, 2021 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (the “Company”)…